A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

NCT04560998 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

792

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Peripheral Arterial Disease

Interventions

DRUG: Semaglutide
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S